Gastric neuroendocrine neoplasms (gNENs) display peculiar site-specific features among
all NENs. Their incidence and prevalence have been rising in the past few decades. gNENs …

Theranostics is the combination of two approaches—diagnostics and therapeutics—applied
for decades in cancer imaging using radiopharmaceuticals or paired radiopharmaceuticals …

Simple Summary Gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NENs) are the
most common neuroendocrine tumors, with the ability of overexpressing somatostatin …

Abstract Background Fluorine-18-labeled SSAs have the potential to become the next-
generation tracer in SSTR-imaging in neuroendocrine tumor (NET) patients given their …

The growing importance of advanced endoscopy in the diagnosis and treatment of
pancreatic neuroendocrine neoplasms (PanNETs) necessitates a comprehensive …

BACKGROUND AND PURPOSE: Due to its high sensitivity, somatostatin receptor–PET may
detect smaller lesions and more extensive disease than contrast-enhanced MR imaging …

Background Radio-guided surgery (RGS) holds promise for improving surgical outcomes in
neuroendocrine tumors (NETs). Previous studies showed low specificity (SP) using γ-probes …

The pursuit of the perfect radionuclide for imaging or therapy is ongoing, as no single choice
can universally meet all applications. The field of nuclear medicine has seen significant …

Introduction Suitability for peptide receptor radionuclide therapy (PRRT) for neuroendocrine
neoplasia (NENs) depends on presence of somatostatin receptor-2 (SSTR2) determined by …

Aims Aim of the present analysis was to report results of a systematic review of the literature
in the setting of patients treated with hypoF PT for benign lesions of the central nervous …